SUPERB - AI SUPported Evaluation of Immunotherapy Response in Early Triple Negative Breast Cancer

September 10, 2025
7 min read
Share this post

Tissue Segmentation: On a holdout dataset, the accuracy for precisely delineating invasive carcinoma tissue structures in images was 92.3%, with a specificity of 99.9% and a sensitivity of 84.7%. In a 3-class scenario - distinguishing between invasive carcinoma, immune, and healthy tissue - the accuracy was 90.0%.

Prediction of pCR: We evaluated the AI using 5-fold cross-validation, achieving a pCR prediction AUC of 0.735±0.017 and an accuracy of 0.68±0.03. The predicted probabilities for responders and non-responders were well-separated, with a p-value of 8.6x10-12.

In our analysis of feature importances, we identified the three most critical feature groups: pathological biomarkers, cell-tissue interactions, and individual cell characteristics. Overall, various AI-based-image-analysis features demonstrated similar levels of importance.

Share this article
h-e
Pathology
Biomarkers
Precision medicine

Elevate Your Diagnostic Workflow with Clinical-Grade AI

Whether you are looking to scale your lab’s capacity with our existing high-performance IHC suites or require a custom AI solution tailored to your specific diagnostic workflow, Mindpeak is your dedicated partner in precision pathology.

Our technology is already trusted in over 40 labs globally and features the most comprehensive integration ecosystem in the industry, with 18+ clinical IMS partner integrations to ensure a "plug-and-play" experience with your existing hardware. Stop manual reader variability and start delivering reproducible, algorithm-driven results for every patient

Join the future of digital pathology with our diagnostic AI platform.

Two angled computer monitors display scientific data with colorful heatmaps and tissue images on a purple background.